MedPath

Tropicamide

Tropicamide Ophthalmic Solution, USP

Approved
Approval ID

0104ffe4-013d-4afa-996d-dcba4f08e93d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 29, 2022

Manufacturers
FDA

Sandoz Inc

DUNS: 005387188

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tropicamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61314-355
Application NumberANDA084306
Product Classification
M
Marketing Category
C73584
G
Generic Name
Tropicamide
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateDecember 16, 2020
FDA Product Classification

INGREDIENTS (7)

TROPICAMIDEActive
Quantity: 10 mg in 1 mL
Code: N0A3Z5XTC6
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tropicamide - FDA Drug Approval Details